← back to search
Ryohei Yoshida
Nishida Hospital · JP
Area of research
Oncology · Immunology
Research interest
Research interests include interferon and immune responses, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, and RNA modifications and cancer.
h-index
9
citations
901
works
65
NIH funding
—
primary concept
Medicine
email
yryohei@asahikawa-med.ac.jp
Recent publications
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Cancer Cell
2022
cited by
99
position: middle
doi
Tumor-Derived cGAMP Regulates Activation of the Vasculature
Frontiers in Immunology
2020
cited by
59
position: middle
doi
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Cancer Discovery
2018
cited by
508
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Marco Campisi
· Dana-Farber Cancer Institute
2
papers (2018–2020)
Shriram K. Sundararaman
· Harvard University
2
papers (2018–2020)
Brandon Piel
· Dana-Farber Cancer Institute
2
papers (2018–2020)
Cloud P. Paweletz
· Harvard University
2
papers (2018–2020)
Shunsuke Kitajima
· Kanazawa University
2
papers (2018–2020)
Tran C. Thai
· Harvard University
2
papers (2018–2020)
David A. Barbie
· Harvard University
2
papers (2018–2020)
Elena V. Ivanova
· Brigham and Women's Hospital
2
papers (2018–2020)
Sarah E. Shelton
· Massachusetts Institute of Technology
1
papers (2020–2020)
—
·
1
papers (2018–2018)
Hideo Watanabe
· St. Catherine University
1
papers (2018–2018)
Valeria Chiono
· Massachusetts Institute of Technology
1
papers (2020–2020)
Tetsuo Tani
· Saiseikai Central Hospital
1
papers (2020–2020)
—
·
1
papers (2018–2018)
Paul T. Kirschmeier
· Center for Cancer Research
1
papers (2018–2018)
Shoichiro Tange
· Sapporo Medical University
1
papers (2018–2018)
Tatsuya Osaki
· Whitehead Institute for Biomedical Research
1
papers (2020–2020)
Sharon Wei Ling Lee
· National University of Singapore
1
papers (2020–2020)
—
·
1
papers (2020–2020)
Navin R. Mahadevan
· Harvard University Press
1
papers (2020–2020)